Charco Neurotech published pilot randomized controlled trial data for CUE1+ in npj Parkinson's Disease. The wearable device attaches to the chest and delivers focused vibrotactile stimulation and rhythmic cueing to ease Parkinson's symptoms. Against a sham control, participants using the active device showed meaningful improvements across motor severity, gait, and falls risk, as well as non-motor symptoms including sleep and quality of life, with minimal adverse effects. The results add controlled evidence to a device already used by thousands of patients.